11:04 pm - Wednesday February 22, 2012

Type 2 Diabetes Global Clinical Trials Review, H2, 2011

Buy This Report Now

Call US : USA-CANADA Toll Free: +1-866-997-948 or +1-518-618-1030

Email: sales@twease.org
Request Sample on This Report

Your Name (required)

Your Email (required)

Your Phone (required)

Report Name (required)

Subject

Your Message

Type 2 Diabetes Global Clinical Trials Review, H2, 2011

Diabetes Devices Market

DescriptionType 2 Diabetes Global Clinical Trials Review, H2, 2011

Summary

GlobalData’s clinical trial report, Type 2 Diabetes Global Clinical Trials Review, H2, 2011″ provides data on the Type 2 Diabetes clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Type 2 Diabetes. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Type 2 Diabetes. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Type 2 Diabetes 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of Type 2 Diabetes 25
Subjects Recruited Over a Period of Time 46
Prominent Sponsors 47
Top Companies Participating in Type 2 Diabetes Therapeutics Clinical Trials 49
Prominent Drug Comparison 51
Clinical Trial Profiles 52
Clinical Trial Overview of Top Companies 52
Novo Nordisk A/S 52
Clinical Trial Overview of Novo Nordisk A/S 52
Merck & Co., Inc. 66
Clinical Trial Overview of Merck & Co., Inc. 66
Novartis AG 74
Clinical Trial Overview of Novartis AG 74
Sanofi 83
Clinical Trial Overview of Sanofi 83
GlaxoSmithKline plc 89
Clinical Trial Overview of GlaxoSmithKline plc 89
Eli Lilly and Company 96
Clinical Trial Overview of Eli Lilly and Company 96
AstraZeneca PLC 102
Clinical Trial Overview of AstraZeneca PLC 102
Amylin Pharmaceuticals, Inc. 109
Clinical Trial Overview of Amylin Pharmaceuticals, Inc. 109
Bristol-Myers Squibb Company 116
Clinical Trial Overview of Bristol-Myers Squibb Company 116
Pfizer Inc. 122
Clinical Trial Overview of Pfizer Inc. 122
Boehringer Ingelheim GmbH 128
Clinical Trial Overview of Boehringer Ingelheim GmbH 128
Takeda Pharmaceutical Company Limited 134
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 134
Johnson & Johnson 138
Clinical Trial Overview of Johnson & Johnson 138
F. Hoffmann-La Roche Ltd. 142
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 142
Abbott Laboratories 145
Clinical Trial Overview of Abbott Laboratories 145
Astellas Pharma Inc. 147
Clinical Trial Overview of Astellas Pharma Inc. 147
MannKind Corporation 149
Clinical Trial Overview of MannKind Corporation 149
Daiichi Sankyo Company, Ltd 151
Clinical Trial Overview of Daiichi Sankyo Company, Ltd 151
Mitsubishi Tanabe Pharma Corporation 153
Clinical Trial Overview of Mitsubishi Tanabe Pharma Corporation 153
SANWA KAGAKU KENKYUSHO CO.,LTD. 154
Clinical Trial Overview of SANWA KAGAKU KENKYUSHO CO.,LTD. 154
Clinical Trial Overview of Top Universities / Institutes / Hospitals 155
The National Institute of Diabetes and Digestive and Kidney Diseases 155
Clinical Trial Overview of the National Institute of Diabetes and Digestive and Kidney Diseases 155
Aarhus University 158
Clinical Trial Overview of Aarhus University 158
Academic Medical Centre 160
Clinical Trial Overview of Academic Medical Centre 160
Department of Health 161
Clinical Trial Overview of Department of Health 161
Maastricht University Medical Center 163
Clinical Trial Overview of Maastricht University Medical Center 163
Vanderbilt University 164
Clinical Trial Overview of Vanderbilt University 164
Mayo Clinic 165
Clinical Trial Overview of Mayo Clinic 165
Park Nicollet Institute 166
Clinical Trial Overview of Park Nicollet Institute 166
Yokohama City University 167
Clinical Trial Overview of Yokohama City University 167
Washington University School of Medicine 168
Clinical Trial Overview of Washington University School of Medicine 168
U.S. Department of Veterans Affairs 169
Clinical Trial Overview of U.S. Department of Veterans Affairs 169
Jikei University School of Medicine 171
Clinical Trial Overview of Jikei University School of Medicine 171
Emory University 172
Clinical Trial Overview of Emory University 172
Kobe University 173
Clinical Trial Overview of Kobe University 173
Osaka University 174
Clinical Trial Overview of Osaka University 174
Erasmus MC 175
Clinical Trial Overview of Erasmus MC 175
Juntendo University School of Medicine 176
Clinical Trial Overview of Juntendo University School of Medicine 176
Leiden University Medical Center 177
Clinical Trial Overview of Leiden University Medical Center 177
Karolinska Institutet 178
Clinical Trial Overview of Karolinska Institutet 178
Kyoto University 179
Clinical Trial Overview of Kyoto University 179
Five Key Clinical Profiles 180
Appendix 205
Abbreviations 205
Definitions 206
Research Methodology 207
Secondary Research 207
About GlobalData 208
Contact Us 208
Disclaimer 208
Source 209

List of Table:List of Tables
Type 2 Diabetes Therapeutics Market, Global, Clinical Trials by Zone, 2011* 9
Type 2 Diabetes Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 10
Type 2 Diabetes Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 11
Type 2 Diabetes Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2011* 12
Type 2 Diabetes Therapeutics Clinical Trials, Europe, Top Five Countries, 2011* 13
Type 2 Diabetes Therapeutics Clinical Trials, North America, Top Countries, 2011* 14
Type 2 Diabetes Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2011* 15
Type 2 Diabetes Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2011* 16
Type 2 Diabetes Therapeutics Clinical Trials, BRIC Countries, 2011* 17
Type 2 Diabetes Therapeutics Clinical Trials, G7 Countries, 2011* 18
Type 2 Diabetes Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2011* 19
Type 2 Diabetes Therapeutics Clinical Trials, E7 Countries, 2011* 20
Type 2 Diabetes Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2011* 21
Type 2 Diabetes Therapeutics Market, Global, Clinical Trials by Phase, 2011* 22
Type 2 Diabetes Therapeutics Market, Global, Clinical Trials In Progress by Phase 2011* 23
Type 2 Diabetes Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 24
Type 2 Diabetes Therapeutics Market, Global, Suspended Clinical Trials, 2011* 25
Type 2 Diabetes Therapeutics Market, Global, Withdrawn Clinical Trials, 2011* 26
Type 2 Diabetes Therapeutics Market, Global, Terminated Clinical Trials, 2011* 28
Type 2 Diabetes Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 46
Type 2 Diabetes Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 48
Type 2 Diabetes Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 50
Type 2 Diabetes Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011* 51
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Novo Nordisk A/S, 2011* 52
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2011* 66
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2011* 74
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2011* 83
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2011* 89
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2011* 96
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2011* 102
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Amylin Pharmaceuticals, Inc., 2011* 109
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2011* 116
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2011* 122
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim GmbH, 2011* 128
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2011* 134
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2011* 138
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2011* 142
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2011* 145
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2011* 147
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by MannKind Corporation, 2011* 149
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Ltd, 2011* 151
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Mitsubishi Tanabe Pharma Corporation, 2011* 153
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by SANWA KAGAKU KENKYUSHO CO.,LTD., 2011* 154
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2011* 155
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2011* 158
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Centre, 2011* 160
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, 2011* 161
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2011* 163
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2011* 164
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2011* 165
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Park Nicollet Institute, 2011* 166
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Yokohama City University, 2011* 167
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2011* 168
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2011* 169
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Jikei University School of Medicine, 2011* 171
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2011* 172
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Kobe University, 2011* 173
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka University, 2011* 174
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2011* 175
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Juntendo University School of Medicine, 2011* 176
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2011* 177
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Karolinska Institutet, 2011* 178
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2011* 179

List of Charts:List of Figures
Type 2 Diabetes Therapeutics Market, Global, Clinical Trials by Zone (%), 2011* 9
Type 2 Diabetes Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 10
Type 2 Diabetes Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 11
Type 2 Diabetes Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2011* 12
Type 2 Diabetes Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2011* 13
Type 2 Diabetes Therapeutics Clinical Trials, North America, Top Countries (%), 2011* 14
Type 2 Diabetes Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2011* 15
Type 2 Diabetes Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2011* 16
Type 2 Diabetes Therapeutics Clinical Trials, BRIC Countries (%), 2011* 17
Type 2 Diabetes Therapeutics Clinical Trials, G7 Countries (%), 2011* 18
Type 2 Diabetes Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2011* 19
Type 2 Diabetes Therapeutics Clinical Trials, E7 Countries (%), 2011* 20
Type 2 Diabetes Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2011* 21
Type 2 Diabetes Therapeutics Market, Global, Clinical Trials by Phase (%), 2011* 22
Type 2 Diabetes Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2011* 23
Type 2 Diabetes Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 24
Type 2 Diabetes Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 46
Type 2 Diabetes Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 47
Type 2 Diabetes Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 49
Type 2 Diabetes Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011* 51
GlobalData Methodology 207

Related posts:

  1. Type 1 Diabetes (Juvenile Diabetes) Global Clinical Trials Review, H2, 2011
  2. Global Diabetes Devices Market & Diabetes Drugs Market (2011- 2016)

Type 2 Diabetes Global Clinical Trials Review, H2, 2011

Buy This Report Now

Call US : USA-CANADA Toll Free: +1-866-997-948 or +1-518-618-1030

Email: sales@twease.org
Request Sample on This Report

Your Name (required)

Your Email (required)

Your Phone (required)

Report Name (required)

Subject

Your Message

Filed in: GlobalData, Pharmaceuticals
China Market Research